Navigation Links
Aurobindo gets U.S. FDA approval for Cephalexin

Aurobindo Pharma Ltd has announced that U.S. Food Drug Administration (US FDA) has approved its Cephalexin capsules USP 250 mg & 500 mg.//

Cephalexin is used to treat many different types of bacterial infections such as bronchitis, tonsillitis, ear infections, skin infections, and urinary tract infections. The company has achieved another major milestone by obtaining the first product approval from the dedicated Cephalosporin facility (Unit VI, situated in Medak District, Andhra Pradesh, India).

The company has set up three (Unit III, Unit VI, Unit XII) multi module formulation manufacturing facilities. Earlier products from Unit III only contributed to the sales in the US. Product approvals from Unit XII and Unit VI have just come, and the company will be in a position to capitalise on this opportunity with immediate effect.

The market opportunity for the Cephalexin capsules USP 250 mg and 500 mg is around $80 million. The company is a leader in this segment in several markets in the world and is looking forward to market its products in the US.
'"/>




Page: 1

Related medicine news :

1. US FDA approved Aurobindo Pharma to produce generic AIDS drug
2. Aurobindo Receives Approval from USFDA for anti-AIDS drug
3. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
4. Aurobindo Pharma Purchases US Manufacturing Facility
5. Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets
6. Aurobindo Gets USFDA Approval for A 3-Drug Combination Pack
7. Ranbaxy gets US FDA approval for Lisinopril
8. Cadila gets US FDA approval for Promethazine tablets
9. Anti-obesity drugs for FDA approval
10. Grand FDA nod and approval for drug for heart transplant patients
11. OTC sale for Xenical; Diet Drug; gets FDA approval
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... 27, 2016 , ... In response to meager public awareness, ... of the plight of aphasia. In collaboration with the American Aphasia Association, a ... The link between stroke and aphasia is relatively unknown, but through collaboration with ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Aimed at nurses ... interest stories, which come courtesy of leaders in the nursing and health care industry. ... leading advocates and associations—namely Abilene Christian University. , As the nursing industry is ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: